Iron Overload, Chelation Therapy and Survival in Lower-Risk Myelodysplastic Syndromes: State of the Evidence

Journal Title: International Blood Research & Reviews - Year 2014, Vol 2, Issue 3

Abstract

Myelodysplastic syndromes (MDS) are clonal stem cell disorders that primarily affect older persons and are associated with peripheral blood cytopenias, increased risk of conversion to acute myeloid leukemia and shortened survival. Treatment strategies in MDS are guided by patient risk categories, with higher-risk patients receiving more aggressive interventions. Patients with lower-risk MDS receive less aggressive therapies or supportive care/red blood cell transfusion. Transfusion-dependent patients with lower-risk MDS are likely to develop iron overload because of their longer predicted survival and, hence, greater transfusion burden. Transfusion requirement and elevated serum ferritin further complicate the treatment landscape because they have dose-dependent effects on overall and leukemia-free survival, with increasing serum ferritin levels associated with increased risk of death. Lower iron burden could provide a survival benefit, and an association with improved survival has been shown in retrospective studies. However, lack of random assignment to treatment is the major flaw in these studies, which potentially introduces patient selection bias. Despite the lack of randomization and other issues with trial design, available studies have shown consistent results, which suggest a survival benefit in transfusion-dependent patients with MDS who have received chelation therapy. Prospective studies are needed to confirm this observation. The possible mechanisms by which chelation therapy appears to benefit patients with MDS need further research. The data suggesting a survival benefit from chelation therapy in lower-risk, iron-overloaded patients with MDS are reviewed, including the strength of evidence, recent scientific advances and ongoing clinical trials.

Authors and Affiliations

Roger M. Lyons

Keywords

Related Articles

Approach to Anaemia Diagnosis in Developing Countries: Focus on Aetiology and Laboratory Work-Up

Introduction: Anaemia is a significant public health problem in developing countries. Anaemia is never normal. The etiology of the anaemia should always be sought. Diagnosis of its cause and early treatment is crucial to...

Iron Status and Red Cell Parameters in Pregnant and Non-pregnant Adolescents in Côte d’Ivoire (West Africa)

Aims: The objective of this study was to evaluate iron metabolism and compare iron stores between pregnant and non-pregnant adolescents in Côte d’Ivoire. Place and Duration of Study: The study was undertaken with 187 vo...

Knowledge of Rh (Rhesus) D Blood Group, Risk Factors and Burden of Rh D Alloimmunisation among Female Secondary School Students in Ikorodu, Lagos, Nigeria

Background: Rh (Rhesus) blood group antigen especially D antigen plays a pivotal role in provision of safe blood and safe pregnancy. Antigen mismatch between blood donor and recipient or pregnant woman and the foetus set...

Sero-prevalence of Hepatitis B Virus among Ambulance Drivers and Mortuary Workers in Plateau State, Nigeria

Aims: To determine the prevalence of Hepatitis B Virus among Ambulance Drivers and Mortuary workers in Plateau State with possible associated risk factors for the infection. Study Design: A cross section, descriptive stu...

Sickle Cell Carrier Frequency and the Need for Genetic/ Pre-marital Counseling among Students of a Nigerian University

Aims: To determine the sickle cell carrier frequency among undergraduate students of a Nigerian University with a view to evaluate the need to institute genetic and premarital counseling program. Methodology: This was a...

Download PDF file
  • EP ID EP242461
  • DOI 10.9734/IBRR/2014/8580
  • Views 111
  • Downloads 0

How To Cite

Roger M. Lyons (2014). Iron Overload, Chelation Therapy and Survival in Lower-Risk Myelodysplastic Syndromes: State of the Evidence. International Blood Research & Reviews, 2(3), 95-112. https://europub.co.uk/articles/-A-242461